A multicenter, real-world study on two oral Truvada approaches to prevent HIV infection among MSM in China (CROPrEP)
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2018
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms CROPrEP
- 28 Jul 2018 Planned number of patients changed from 1500 to 1000.
- 28 Jul 2018 Planned initiation date changed from 1 Jan 2018 to 1 Sep 2018.
- 11 Dec 2017 New trial record